Clinical trials
Phase 1 Myositis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Fate Therapeutics | 1 |
| GlaxoSmithKline | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 7 |
| Myositis | 7 |
| Arthritis, Rheumatoid | 6 |
| Scleroderma, Systemic | 5 |
| Autoimmune Diseases | 3 |
| Dermatomyositis | 3 |
| Lupus Nephritis | 3 |
| Musculoskeletal Diseases | 2 |
| Polymyositis | 2 |
| Scleroderma, Diffuse | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.